| Richard Kent Wagner, MD | |
|
263 Farmington Avenue, Farmington, CT 06030-8085 | |
| (860) 679-3387 | |
| (860) 679-1494 |
| Full Name | Richard Kent Wagner |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 263 Farmington Avenue, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003858952 | NPI | - | NPPES |
| 03079002 | Medicaid | MS | |
| 160058729 | Other | RR MEDICARE | |
| 4039002 | Other | BCBS | |
| 8LP486 | Other | TX | BCBS |
| 362343103 | Medicaid | TX | |
| P02351968 | Other | TX | MEDICARE RAIL ROAD |
| 3862861 | Medicaid | TN | |
| 861880 | Other | TX | MEDICARE |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies' ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.
Researchers at Johns Hopkins have launched the first government-sponsored study to measure the effectiveness of a Web- and community-based home test kit for common sexually transmitted diseases, such as Chlamydia and gonorrhea.
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.
The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer's disease. Working through Cure Network Ventures, Inc., the new company will help expedite the translation of relevant scientific discoveries from the Gladstone Institute of Neurological Disease into the development of potential therapies.
› Verified 6 days ago
| Entity Name | Connecticut Children's Specialty Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669448882 PECOS PAC ID: 6002720117 Enrollment ID: O20031113000468 |
News Archive
DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies' ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.
Researchers at Johns Hopkins have launched the first government-sponsored study to measure the effectiveness of a Web- and community-based home test kit for common sexually transmitted diseases, such as Chlamydia and gonorrhea.
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.
The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer's disease. Working through Cure Network Ventures, Inc., the new company will help expedite the translation of relevant scientific discoveries from the Gladstone Institute of Neurological Disease into the development of potential therapies.
› Verified 6 days ago
| Entity Name | Bristol Hospital Multi-specialty Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649265679 PECOS PAC ID: 9032014758 Enrollment ID: O20031204000960 |
News Archive
DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies' ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.
Researchers at Johns Hopkins have launched the first government-sponsored study to measure the effectiveness of a Web- and community-based home test kit for common sexually transmitted diseases, such as Chlamydia and gonorrhea.
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.
The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer's disease. Working through Cure Network Ventures, Inc., the new company will help expedite the translation of relevant scientific discoveries from the Gladstone Institute of Neurological Disease into the development of potential therapies.
› Verified 6 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies' ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.
Researchers at Johns Hopkins have launched the first government-sponsored study to measure the effectiveness of a Web- and community-based home test kit for common sexually transmitted diseases, such as Chlamydia and gonorrhea.
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.
The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer's disease. Working through Cure Network Ventures, Inc., the new company will help expedite the translation of relevant scientific discoveries from the Gladstone Institute of Neurological Disease into the development of potential therapies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Kent Wagner, MD 263 Farmington Avenue, Farmington, CT 06030-8085 Ph: (860) 679-3387 | Richard Kent Wagner, MD 263 Farmington Avenue, Farmington, CT 06030-8085 Ph: (860) 679-3387 |
News Archive
DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies' ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.
Researchers at Johns Hopkins have launched the first government-sponsored study to measure the effectiveness of a Web- and community-based home test kit for common sexually transmitted diseases, such as Chlamydia and gonorrhea.
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.
In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.
The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer's disease. Working through Cure Network Ventures, Inc., the new company will help expedite the translation of relevant scientific discoveries from the Gladstone Institute of Neurological Disease into the development of potential therapies.
› Verified 6 days ago
Dr. Claudio A. Benadiva, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2 Batterson Park Rd, Farmington, CT 06032 Phone: 860-679-4580 | |
Molly Brewer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Uconn Medical Group/neag Cancer Center, Farmington, CT 06030 Phone: 860-679-2100 Fax: 860-679-4815 | |
Reeva Makhijani, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2 Batterson Park Rd, Farmington, CT 06032 Phone: 844-467-3483 | |
Donald B Maier, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2 Batterson Park Rd, Farmington, CT 06032 Phone: 860-678-3428 | |
Nicole Gavin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2329 Fax: 860-679-1494 | |
Dr. Chito Umenyi Nwana, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2853 |